BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 7013039)

  • 41. Successful living donor kidney transplantation across HLA and ABO incompatibilities.
    Magee CC; Mah H; Tinckam K; Wood I; Ji F; Powelson J
    Nephrol Dial Transplant; 2007 Feb; 22(2):602-4. PubMed ID: 17132704
    [No Abstract]   [Full Text] [Related]  

  • 42. Present status of ABO-incompatible kidney transplantation in Japan.
    Takahashi K; Saito K
    Xenotransplantation; 2006 Mar; 13(2):118-22. PubMed ID: 16623804
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [HLA-DR and kidney transplant].
    Andreu J; Esteller E
    Med Clin (Barc); 1983 Mar; 80(7):327-33. PubMed ID: 6222226
    [No Abstract]   [Full Text] [Related]  

  • 44. Successful living donor renal transplantation despite ABO incompatibility and a positive crossmatch.
    Kayler LK; Colombe B; Farber JL; Lacava D; Dafoe DC; Burke JF; Francos GC; Ratner LE
    Clin Transplant; 2004 Dec; 18(6):737-42. PubMed ID: 15516254
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Warm B-cell antibodies and DRw matching: their influence on transplant outcome at a single center.
    Coxe-Gilliland R; Cross DE
    Transplant Proc; 1981 Mar; 13(1 Pt 2):945-8. PubMed ID: 7022967
    [No Abstract]   [Full Text] [Related]  

  • 46. HLA-DR matching: the impact on cadaveric renal transplantation. A single-center study.
    Madsen M; Graugaard B; Fjeldborg O; Posborg V; Hansen HE; Lamm LU; Kissmeyer-Nielsen F
    Scand J Urol Nephrol Suppl; 1981; 64():56-63. PubMed ID: 6815794
    [No Abstract]   [Full Text] [Related]  

  • 47. ABH and Lewis antigens on lymphocytes: screening of pregnant women's sera with the B-cell cytotoxicity test.
    Park MS; Oriol R; Nakata S; Terasaki PI; Ford R; Bernoco D
    Transplant Proc; 1979 Dec; 11(4):1947-9. PubMed ID: 394439
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Histocompatibility. Influence of HLA-DR matching on renal graft survival. A Scandiatransplant report.
    Moen T; Berger L; Goyer K; Dahl O; Thorsby E
    Scand J Urol Nephrol Suppl; 1981; 64():30-7. PubMed ID: 6815792
    [No Abstract]   [Full Text] [Related]  

  • 49. Blood transfusions, HLA-A and B, DR matching, graft survival, and clinical course after cadaveric kidney transplantation.
    van Es A; Persijn GG; van Hooff-Eijkenboom YE; Kalff MW; van Hooff JP
    Transplant Proc; 1981 Mar; 13(1 Pt 1):172-4. PubMed ID: 7022816
    [No Abstract]   [Full Text] [Related]  

  • 50. Cadaveric kidney transplantation in patients with lymphocytotoxic autoantibodies.
    Emonds MP; Dendievel J; Roels L; Waer M; Vanrenterghem Y; Vermylen C
    Transplant Proc; 1992 Dec; 24(6):2502-3. PubMed ID: 1465845
    [No Abstract]   [Full Text] [Related]  

  • 51. [Immunoadsorption of anti-B antibodies as preparation for an ABO-incompatible kidney transplantation].
    Aeschbacher B; Wiedmer W; Stuck A; Gaenger KH; Frey FJ; Nydegger UE
    Schweiz Med Wochenschr; 1987 May; 117(19):716-22. PubMed ID: 3296166
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Controlled trial of HLA-A, B, versus HLA-DR matching in cadaveric renal transplantation.
    d'Apice AJ; Sheil AG; Tait BD; Bashir HV
    Transplant Proc; 1981 Mar; 13(1 Pt 2):938-41. PubMed ID: 7022965
    [No Abstract]   [Full Text] [Related]  

  • 53. Transplantation of ABO-incompatible and living unrelated donor-recipient combinations.
    Ishikawa N; Yagisawa T; Sakuma Y; Fujiwara T; Nukui A; Yashi M; Miyamoto N
    Transplant Proc; 2008 Sep; 40(7):2292-3. PubMed ID: 18790215
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical relevance of Luminex donor-specific crossmatches: data from 165 renal transplants.
    Billen EV; Christiaans MH; van den Berg-Loonen EM
    Tissue Antigens; 2009 Sep; 74(3):205-12. PubMed ID: 19497037
    [TBL] [Abstract][Full Text] [Related]  

  • 55. HLA-DRW6 and autoantibodies in recipients of first kidney grafts.
    Reekers P; Raaben W; van der Beucken M; Kunst V; Hoitsma A; Koene R
    Transplant Proc; 1984 Oct; 16(5):1159-61. PubMed ID: 6385364
    [No Abstract]   [Full Text] [Related]  

  • 56. Accommodation: does it apply to human leukocyte antigens?
    Rose ML; West LJ
    Transplantation; 2012 Feb; 93(3):244-6. PubMed ID: 22167050
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Influence of HLA-A, B, C, D, and DR matching in renal transplantation.
    Albrechtsen D; Moen T; Flatmark A; Halvorsen S; Jakobsen A; Jervell J; Solheim BG; Thorsby E
    Transplant Proc; 1981 Mar; 13(1 Pt 2):924-9. PubMed ID: 7022962
    [No Abstract]   [Full Text] [Related]  

  • 58. The importance of tissue typing in cadaveric kidney transplantation (pros).
    Sirchia G
    Contrib Nephrol; 1982; (34):101-10. PubMed ID: 6756776
    [No Abstract]   [Full Text] [Related]  

  • 59. Absence of irreversible rejection in the presence of warm anti-donor-HLA class I cytotoxic IgG antibody.
    Shoker A; Klassen J; Herbut B
    Clin Nephrol; 1997 Feb; 47(2):87-91. PubMed ID: 9049455
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Xenotransplantation and ABO incompatible transplantation: the similarities they share.
    Galili U
    Transfus Apher Sci; 2006 Aug; 35(1):45-58. PubMed ID: 16905361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.